These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3499211)

  • 61. Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy.
    Chard RL; Finklestein JZ; Sonley MJ; Nesbit M; McCreadie S; Weiner J; Sather H; Hammond GD
    Med Pediatr Oncol; 1978; 4(3):263-73. PubMed ID: 355821
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The feasibility of opal/high dose Ara-C treatment of adult acute lymphoblastic leukaemia.
    Barnett MJ; Rohatiner AZ; Richards MA; Waxman JH; Ganesan TS; Miller A; Biruls R; Lister TA
    Haematol Blood Transfus; 1985; 29():53-5. PubMed ID: 3861489
    [No Abstract]   [Full Text] [Related]  

  • 63. Therapy of acute lymphocytic leukemia in childhood with intermediate dose methotrexate and CNS irradiation. A report of the ALL 77-02 study group.
    Haas RJ; Janka G; Gaedicke G; Kohne E; Netzel B
    Blut; 1983 Dec; 47(6):321-31. PubMed ID: 6580929
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
    Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
    Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.
    Winick NJ; Smith SD; Shuster J; Lauer S; Wharam MD; Land V; Buchanan G; Rivera G
    J Clin Oncol; 1993 Feb; 11(2):271-8. PubMed ID: 8426204
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
    Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493).
    Frankel LS; Ochs J; Shuster JJ; Dubowy R; Bowman WP; Hockenberry-Eaton M; Borowitz M; Carroll AJ; Steuber CP; Pullen DJ
    J Pediatr Hematol Oncol; 1997; 19(1):35-42. PubMed ID: 9065717
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Therapeutic results in non-T non-B acute lymphoblastic leukemia in the adult with intensive postremission chemotherapy].
    Sanz G; Sanz MA; Rafecas FJ; Martínez JA; Amigó V; Martín-Aragonés G; Gomis F; Lorenzo I; Marty ML
    Sangre (Barc); 1984; 29(6):1018-29. PubMed ID: 6598234
    [No Abstract]   [Full Text] [Related]  

  • 70. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.
    Conter V; Valsecchi MG; Silvestri D; Campbell M; Dibar E; Magyarosy E; Gadner H; Stary J; Benoit Y; Zimmermann M; Reiter A; Riehm H; Masera G; Schrappe M
    Lancet; 2007 Jan; 369(9556):123-31. PubMed ID: 17223475
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group.
    Miller DR; Leikin S; Albo V; Sather H; Karon M; Hammond D
    Cancer; 1983 Mar; 51(6):1041-9. PubMed ID: 6336986
    [No Abstract]   [Full Text] [Related]  

  • 72. A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia.
    McCredie KB; Freireich EJ; Bodey GP; Burgess MA; Whitecar JP; Smith TL
    Med Pediatr Oncol; 1976; 2(3):309-18. PubMed ID: 979915
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL).
    Sallan SE; Camitta BM; Chan DM; Traggis D; Jaffe N
    Med Pediatr Oncol; 1977; 3(4):359-64. PubMed ID: 270608
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A study of "total therapy" of acute lymphocytic leukemia in children.
    George P; Hernandez K; Hustu O; Borella L; Holton C; Pinkel D
    J Pediatr; 1968 Mar; 72(3):399-408. PubMed ID: 5237796
    [No Abstract]   [Full Text] [Related]  

  • 75. Remission continuation therapy for adult acute lymphoblastic leukemia. Preliminary results with a multidrug treatment protocol.
    Rossi G; Verzura P; Marpicati P; Zaniboni A; Ferremi P; Marini G; Marinone G
    Chemioterapia; 1984 Jun; 3(3):147-51. PubMed ID: 6597732
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
    Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
    Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
    Michel G; Landman-Parker J; Auclerc MF; Mathey C; Leblanc T; Legall E; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Auvrignon A; Berthou C; Bauduer F; Pautard B; Schneider P; Schaison G; Leverger G; Baruchel A
    J Clin Oncol; 2000 Apr; 18(7):1517-24. PubMed ID: 10735900
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Acute lymphoblastic leukemia in childhood: the COALL studies].
    Janka GE; Winkler K; Jürgens H; Göbel U; Gutjahr P; Spaar HJ
    Klin Padiatr; 1986; 198(3):171-7. PubMed ID: 3523023
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Usefulness of cytosine arabinoside (NSC-63878) and prednisone (NSC-10023) in refractory childhood lymphoblastic leukemia.
    Nesbit ME; Sonley M; Hammond D
    Med Pediatr Oncol; 1976; 2(1):61-8. PubMed ID: 1064743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.